Product Name: Anti-NGF Antibody (PG110)
Biological Function:
Anti-NGF Antibody (PG110) is a highly specific antibody that targets the nerve growth factor (NGF) protein. NGF is a neurotrophic factor that plays a crucial role in the development and maintenance of the nervous system. It promotes the survival and growth of nerve cells, as well as the formation of synapses. However, in certain conditions, such as chronic pain and neurodegenerative diseases, excessive levels of NGF can cause inflammation and pain. Anti-NGF Antibody (PG110) binds to NGF and blocks its activity, providing a potential therapeutic approach for these conditions.
Main Applications:
Anti-NGF Antibody (PG110) has a wide range of potential applications in the biotech industry. It can be used as a research tool for studying the role of NGF in various biological processes. Additionally, it has potential as a therapeutic agent for conditions such as chronic pain, osteoarthritis, and Alzheimer’s disease, where NGF plays a significant role. The antibody’s high specificity and potency make it a valuable tool for both basic research and drug development.
Experimental Use Cases:
Anti-NGF Antibody (PG110) has been extensively tested in various experimental models, demonstrating its efficacy in blocking NGF activity. In a pre-clinical study, the antibody was able to reduce pain behaviors in a rat model of osteoarthritis, providing evidence for its potential as a pain reliever. In another study, it was shown to reduce the levels of inflammatory markers in a mouse model of Alzheimer’s disease, suggesting its potential as a treatment for neuroinflammation. These results highlight the versatility and effectiveness of Anti-NGF Antibody (PG110) in different experimental settings.
Anti-NGF Antibody (PG110) is a highly specific and potent antibody that targets the nerve growth factor (NGF) protein. Its main applications include research and potential therapeutic use in conditions such as chronic pain and neurodegenerative diseases. In various experimental models, it has demonstrated its efficacy in blocking NGF activity and reducing pain and inflammation. With its high specificity and potency, Anti-NGF Antibody (PG110) is a valuable tool for both basic research and drug development.
Structure:
Biological Function
Anti-NGF Antibody (PG110) targets the nerve growth factor (NGF) protein, which plays a crucial role in the development and maintenance of the nervous system. It promotes the survival and growth of nerve cells and the formation of synapses. However, in certain conditions, excessive levels of NGF can cause inflammation and pain.
Main Applications
Anti-NGF Antibody (PG110) has a wide range of potential applications, including research and therapeutic use. It can be used as a research tool to study the role of NGF in various biological processes. Additionally, it has potential as a therapeutic agent for conditions such as chronic pain, osteoarthritis, and Alzheimer’s disease.
Experimental Use Cases
Extensive testing of Anti-NGF Antibody (PG110) in various experimental models has shown its efficacy in blocking NGF activity. In pre-clinical studies, it has been shown to reduce pain behaviors in a rat model of osteoarthritis and reduce inflammatory markers in a mouse model of Alzheimer’s disease.
Anti-NGF Antibody (PG110) is a highly specific and potent antibody with a wide range of potential applications in the biotech industry. Its main applications include research and potential therapeutic use in conditions such as chronic pain and neurodegenerative diseases. In various experimental models, it has demonstrated its efficacy in blocking NGF activity and reducing pain and inflammation. With its high specificity and potency, Anti-NGF Antibody (PG110) is a valuable tool for both basic research and drug development.
There are no reviews yet.